BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260409T130000
DTEND;TZID=America/Los_Angeles:20260409T170000
DTSTAMP:20260604T012954
CREATED:20260312T165205Z
LAST-MODIFIED:20260312T165205Z
UID:10001041-1775739600-1775754000@www.califesciences.org
SUMMARY:CGT Symposium: In Vivo CAR-T Innovation
DESCRIPTION:One‑day symposium to bring together leading experts to discuss the rapidly evolving landscape of in vivo CAR-T. \nIn vivo CAR-T has attracted significant attention from venture capital and the pharmaceutical industry. By offering the potential to overcome some of the most persistent constraints of ex vivo CAR-T\, including expensive and complex workflows and limited scalability\, this approach addresses challenges that often create financial barriers to patient access. At the same time\, new scientific and engineering solutions are needed to tackle issues such as achieving efficient and selective in vivo delivery\, controlling CAR expression\, and improving safety and efficacy in order to build a reliable therapeutic modality. \nThe Bay Area In Vivo CAR-T Symposium aims to bring together scientists to discuss the emerging challenges and innovations shaping this rapidly evolving field. Through short talks and discussions\, the event seeks to foster dialogue and collaboration across the growing ecosystem of researchers working to turn the promise of in vivo CAR-T into reality. \nThe symposium will be held at Timber & Tide from 1:00 to 5:00 PM\, followed by a networking happy hour from 5:00 to 6:00 PM. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/cgt-symposium-in-vivo-car-t-innovation/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260409T083000
DTEND;TZID=America/Los_Angeles:20260409T123000
DTSTAMP:20260604T012954
CREATED:20260226T211440Z
LAST-MODIFIED:20260327T191939Z
UID:10001023-1775723400-1775737800@www.califesciences.org
SUMMARY:Beyond the Tipping Point
DESCRIPTION:How Life Science Leaders Are Protecting Margin and Benefits in the Age of Healthcare Inflation and AI\nHosted by California Life Sciences and HUB International\, these exclusive forums bring together HR\, Finance\, and Executive leaders from life science companies for a data-driven conversation about two tipping points reshaping their businesses simultaneously\, the unsustainable trajectory of healthcare costs and the AI transformation reshaping every workplace. \nThis program is ideal for HR\, Finance\, and Executive leaders from life science companies with 200-3\,000 employees to gain the information and frameworks they need to lead boldly in a disrupted environment. \nHosted in two convenient locations\, this program is designed to foster connections\, spark conversation\, and explore pressing questions on AI adoption and healthcare purchasing \n\nApril 8\, 8:30-12:30PM | South San Francisco (Timber + Tide on Gateway Blvd) – Click here to RSVP\nApril 9\, 8:30AM-12:30PM | San Diego (The Boardwalk at Science Center Drive) – Click here to RSVP\n\nProgram\n8:30AM | Registration\, Breakfast\, Networking\n9:00AM-12:00PM | Programming\nMilliman – The Healthcare Cost Crisis: Why the Status Quo Is No Longer Viable \nHealthcare costs have reached a tipping point. For employers and plan sponsors\, the question is no longer whether to act — it’s whether you can afford not to. \nMilliman’s experts will make the case for why the status quo is broken and what high-performance companies are doing differently. Drawing on proprietary research and real-world data\, this session unpacks the forces driving today’s healthcare cost crisis — from the seismic impact of GLP-1 medications on pharmacy spend\, to mounting fiduciary obligations under ERISA\, to the hidden costs buried in PBM contracts that most employers never see coming. \nThe takeaway isn’t just a diagnosis — it’s a playbook. Attendees will leave with concrete strategies to close the transparency gap\, manage spiraling Rx costs\, and make smarter\, data-driven benefits decisions that protect both their people and their bottom line. \nThe status quo is no longer viable. This session will show you what’s next. \nHUB International & Pareto Health – The Path Forward: Self-Funded Captive Solutions for Life Science Companies \nThe deck is stacked. Fully-insured carriers have engineered their products to ensure one outcome — that they win. For California employers between 300 and 1\,500 employees\, that means absorbing unpredictable cost increases year after year while having little visibility into what’s actually driving them. \nBut there’s a growing divide between companies that have accepted this arrangement as inevitable and those that haven’t. High-performance employers in this size range are discovering that partially self-insuring — long considered the domain of large enterprises — is not only accessible\, it may be the most powerful lever available to control costs\, improve plan performance\, and deliver better outcomes for their employees. \nThis session is designed specifically for HR and Finance leaders who haven’t yet explored self-insurance — not to sell you on it\, but to equip you with the knowledge to evaluate whether it’s right for your company\, risk tolerance\, and your long-term total rewards objectives. \nBecause the first step to breaking the cycle isn’t a decision — it’s due diligence. \nMcKinsey & Company – Beyond the Tipping Point: AI\, Leadership\, and the Cost of Waiting \nThe McKinsey Global Institute brings its latest research on AI and the future of work to the Life Sciences & Pharma sector\, offering a data-driven look at what may be the most significant workforce transformation in a century. With 68% of jobs requiring fundamental reimagination by 2030 and AI fluency demand growing 4.7x faster than any other skill\, pharma and medical manufacturing organizations face urgent decisions about how to adapt. This presentation breaks down how work will be divided between people\, AI agents\, and robots; which roles and skills face the greatest disruption; and how leaders can navigate the shift through workflow redesign\, smart skilling\, and talent redeployment — with up to $31 billion in economic value potentially on the line for the sector in the US. \n12:00PM | Keynote Speaker & Lunch\n\nSan Diego Only | Fireside Chat with Rick Neale\, EVP and Chief Growth Officer of Scripps Health \nTo close the program\, we go inside the system itself. \nRick Neale\, EVP and Chief Growth Officer at Scripps Health\, brings a perspective that few executives are willing to offer publicly — an unfiltered look at the structural pressures bearing down on hospital and provider systems\, and what they mean for the employers and employees on the other side of the bill. \nAs the architect of Scripps’ strategic growth and the lead voice in the high-stakes Scripps/Anthem negotiations\, Rick sits at the exact intersection of cost\, access\, and institutional survival that defines today’s healthcare crisis. What’s driving costs isn’t abstract — its decisions being made right now\, in real time\, by health systems navigating their own unsustainable realities. \nThis is your opportunity to hear directly from the other side of the table — and to ask the questions that rarely get answered in a boardroom. \n\nThis event is closed to service provider attendees that are not current members of California Life Sciences. Contact BD@califesciences.org to learn more about becoming a member. \nREGISTER FOR THE SAN DIEGO EVENT» \nHosted in partnership with:
URL:https://www.califesciences.org/event/beyond-the-tipping-point-sd/
LOCATION:The Boardwalk at Science Center Drive\, 10275 Science Center Drive\, San Diego\, CA\, 92121\, United States
CATEGORIES:California Life Sciences,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260408T083000
DTEND;TZID=America/Los_Angeles:20260408T123000
DTSTAMP:20260604T012954
CREATED:20260226T211257Z
LAST-MODIFIED:20260327T191713Z
UID:10001022-1775637000-1775651400@www.califesciences.org
SUMMARY:Beyond the Tipping Point
DESCRIPTION:How Life Science Leaders Are Protecting Margin and Benefits in the Age of Healthcare Inflation and AI\nHosted by California Life Sciences and HUB International\, these exclusive forums bring together HR\, Finance\, and Executive leaders from life science companies for a data-driven conversation about two tipping points reshaping their businesses simultaneously\, the unsustainable trajectory of healthcare costs and the AI transformation reshaping every workplace. \nThis program is ideal for HR\, Finance\, and Executive leaders from life science companies with 200-3\,000 employees to gain the information and frameworks they need to lead boldly in a disrupted environment. \nHosted in two convenient locations\, this program is designed to foster connections\, spark conversation\, and explore pressing questions on AI adoption and healthcare purchasing \n\nApril 8\, 8:30-12:30PM | South San Francisco (Timber + Tide on Gateway Blvd) – Click here to RSVP\nApril 9\, 8:30AM-12:30PM | San Diego (The Boardwalk at Science Center Drive) – Click here to RSVP\n\nProgram\n8:30AM | Registration\, Breakfast\, Networking\n9:00AM-12:00PM | Programming\nMilliman – The Healthcare Cost Crisis: Why the Status Quo Is No Longer Viable \nHealthcare costs have reached a tipping point. For employers and plan sponsors\, the question is no longer whether to act — it’s whether you can afford not to. \nMilliman’s experts will make the case for why the status quo is broken and what high-performance companies are doing differently. Drawing on proprietary research and real-world data\, this session unpacks the forces driving today’s healthcare cost crisis — from the seismic impact of GLP-1 medications on pharmacy spend\, to mounting fiduciary obligations under ERISA\, to the hidden costs buried in PBM contracts that most employers never see coming. \nThe takeaway isn’t just a diagnosis — it’s a playbook. Attendees will leave with concrete strategies to close the transparency gap\, manage spiraling Rx costs\, and make smarter\, data-driven benefits decisions that protect both their people and their bottom line. \nThe status quo is no longer viable. This session will show you what’s next. \n  \nHUB International & Pareto Health – The Path Forward: Self-Funded Captive Solutions for Life Science Companies \nThe deck is stacked. Fully-insured carriers have engineered their products to ensure one outcome — that they win. For California employers between 300 and 1\,500 employees\, that means absorbing unpredictable cost increases year after year while having little visibility into what’s actually driving them. \nBut there’s a growing divide between companies that have accepted this arrangement as inevitable and those that haven’t. High-performance employers in this size range are discovering that partially self-insuring — long considered the domain of large enterprises — is not only accessible\, it may be the most powerful lever available to control costs\, improve plan performance\, and deliver better outcomes for their employees. \nThis session is designed specifically for HR and Finance leaders who haven’t yet explored self-insurance — not to sell you on it\, but to equip you with the knowledge to evaluate whether it’s right for your company\, risk tolerance\, and your long-term total rewards objectives. \nBecause the first step to breaking the cycle isn’t a decision — it’s due diligence. \n  \nMcKinsey & Company – Beyond the Tipping Point: AI\, Leadership\, and the Cost of Waiting \nThe McKinsey Global Institute brings its latest research on AI and the future of work to the Life Sciences & Pharma sector\, offering a data-driven look at what may be the most significant workforce transformation in a century. With 68% of jobs requiring fundamental reimagination by 2030 and AI fluency demand growing 4.7x faster than any other skill\, pharma and medical manufacturing organizations face urgent decisions about how to adapt. This presentation breaks down how work will be divided between people\, AI agents\, and robots; which roles and skills face the greatest disruption; and how leaders can navigate the shift through workflow redesign\, smart skilling\, and talent redeployment — with up to $31 billion in economic value potentially on the line for the sector in the US. \n\n12:00PM | Lunch & Networking\nThis event is closed to service provider attendees that are not current members of California Life Sciences. Contact BD@califesciences.org to learn more about becoming a member. \nREGISTER FOR THE SAN FRANCISCO EVENT» \nHosted in partnership with:
URL:https://www.califesciences.org/event/beyond-the-tipping-point-ssf/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260408T070000
DTEND;TZID=America/Los_Angeles:20260408T080000
DTSTAMP:20260604T012954
CREATED:20260312T164513Z
LAST-MODIFIED:20260312T164513Z
UID:10001039-1775631600-1775635200@www.califesciences.org
SUMMARY:How to Simplify ADC Characterization
DESCRIPTION:Characterizing a lysine-conjugated ADC with 3-4 drug molecules scattered across dozens of possible sites is a daunting analytical challenge — but with the right enzymatic strategy and analytical workflows\, it becomes straightforward. Arginine-specific digestion with GingisREX eliminates the missed cleavages that plague trypsin-based peptide mapping of conjugated lysines\, producing cleaner chromatograms and more reliable quantification. When paired with Byos intact reconstruction\, peptide-level and intact-level results can be directly compared — giving you orthogonal confirmation of drug loading in a single analysis. \nIn this webinar\, Genovis will introduce their GlyCLICK® platform for site-specific ADC generation and their enzymatic tools for ADC characterization\, followed by Protein Metrics demonstrating how Byos workflows — PTM analysis\, ADC intact DAR calculation\, and intact reconstruction — enable comprehensive characterization of lysine-conjugated ADCs. \nWhat You Will Learn\n\nHow site-specific conjugation with GlyCLICK simplifies ADC generation and analysis\nWhy arginine-specific digestion with GingisREX produces cleaner peptide maps for lysine-conjugated ADCs\nHow to use Byos PTM and ADC workflows for peptide-level and intact-level characterization\nHow intact reconstruction correlates peptide mapping data with intact mass data for orthogonal DAR confirmation\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-simplify-adc-characterization/
LOCATION:https://www.califesciences.org/event/how-to-simplify-adc-characterization/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260409
DTSTAMP:20260604T012954
CREATED:20260211T201453Z
LAST-MODIFIED:20260211T201702Z
UID:10000979-1775606400-1775692799@www.califesciences.org
SUMMARY:From the Laboratory to Leadership - San Francisco
DESCRIPTION:It’s both an incredibly exciting and challenging time for the life science industry. Some companies are enjoying tailwinds as the result of great clinical data\, their proximity to product approval\, or they find themselves in a hot therapeutic space. Others\, may be more challenged\, as access to capital remains difficult\, putting their progress through the clinic in jeopardy\, or they may be trying to accelerate performance with fewer\, yet\, highly critical people. \nWhether you are scaling your organization for growth or right-sizing your company and upskilling your talent\, people are at the heart of everything you do. They are the innovators\, the motivators\, the problem solvers and your source of inspiration. At their best\, together\, they accelerate the pace at which you bring outstanding\, life-changing solutions to the patients who need them. \nHighly talented\, skilled and aligned leadership has never been more critical. We can help. \nOver 35 years of experience in organizational development is reflected in our From the Laboratory To Leadership program. By leveraging our extensive industry-specific knowledge combined with the most progressive and engaging professional development methods available\, we have successfully transformed over 7500 science-minded\, first-time managers\, into highly capable and confident business leaders. (do we want to say highly capable and confident leaders of people?). \nFrom the Laboratory to Leadership begins by helping participants assess who they are as leaders – their strengths\, styles\, and personal brand. From there\, we develop skills in the areas of communication\, priority management\, meeting management\, goal setting and planning\, delegation\, performance management\, and leading teams in a dynamic workplace. We wrap up the program in a fashion that brings all the learning together in a fun and impactful way. To drive high levels of engagement and impact\, this program integrates learning pods\, encourages participants to use their companies as learning labs\, and helps clients set goals that deliver measurable results. \n\nThis in-person workshop takes place in San Francisco on April 8\, April 22\, May 6\, and May 20 from 8:30 a.m. to 4:30 p.m. PT. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-the-laboratory-to-leadership-san-francisco/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260407T090000
DTEND;TZID=America/Los_Angeles:20260409T163000
DTSTAMP:20260604T012954
CREATED:20260217T165156Z
LAST-MODIFIED:20260217T165156Z
UID:10001018-1775552400-1775752200@www.califesciences.org
SUMMARY:3-Day Lyophilization Technology Training Course: Product\, Processes & Systems
DESCRIPTION:Biopharma Technology\, LLC\, is hosting a 3-day product\, process\, and systems workshop\, from April 7th to April 9th\,2026 at the modern Future Facility™ at Open Biopharma Research and Training Institute in Carlsbad. \nWith over 18 hours of lyophilization content\, this 3-day comprehensive lyo training course provides an opportunity to explore a wide range of elements across the lyophilization process. From characterization of products to cycle development and scale up\, we cover the science and engineering of lyophilization. \nDuring the course we will also discuss fundamental equipment features of refrigeration\, vacuum and control systems i.e. PAT tools\, and aspects of troubleshooting\, maintenance and qualification making it ideal for anyone in the pharmaceutical\, biotech\, or diagnostic sectors seeking to expand their knowledge of lyophilization. \nSecure your place today – Register Today (Pay by card or pro forma invoice) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lyophilization-technology-training-course/
LOCATION:Open Biopharma Research and Training Institute\, 1958 Kellogg Ave\, Carlsbad\, CA\, 92009\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260406T083000
DTEND;TZID=America/Los_Angeles:20260406T153000
DTSTAMP:20260604T012954
CREATED:20251113T181510Z
LAST-MODIFIED:20251113T181510Z
UID:10000947-1775464200-1775489400@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | Virtual
DESCRIPTION:Elevate the pace\, performance\, and culture of your company’s greatest assets. Built from over 30 years of success with more than 7\,500 graduates from over 1\,000 life science companies\, From the Laboratory to Leadership program guides first-time managers\, and those seeking to expand their management skills\, into capable business leaders. This fully redesigned program leverages extensive industry-specific knowledge and experience to utilize the most progressive and engaging professional development methods available. \nProgram dates: April 6\, April 20\, May 4\, and May 18 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/laboratory-to-leadership-virtual/
LOCATION:https://www.califesciences.org/event/laboratory-to-leadership-virtual/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260402T100000
DTEND;TZID=America/Los_Angeles:20260402T130000
DTSTAMP:20260604T012954
CREATED:20260305T204138Z
LAST-MODIFIED:20260305T204138Z
UID:10001034-1775124000-1775134800@www.califesciences.org
SUMMARY:Herding Cats 3.0: Big Pharma Panel
DESCRIPTION:What does it really take to build a successful strategic partnership in life sciences? For today’s business development leaders\, identifying which opportunities will genuinely help accelerate growth can be challenging. \nIn this dynamic program\, attendees will hear from Johnson & Johnson’s External Innovation Group deal-making experts\, who will provide strategic guidance on core collaboration capabilities such as: \n\nPartnership lifecycle management\nValuation fundamentals\nNegotiation and communication strategies\n\nFollowing the main presentation\, attendees will be invited to join an exclusive panel discussion featuring Lesley Stolz\, Head of West North America\, External Scientific Innovation\, Johnson & Johnson\, alongside additional Big Pharma representatives\, who will share how established organizations evaluate partnership opportunities and what emerging companies should understand when engaging with large pharmaceutical partners. \nDesigned specifically for business development professionals\, life science innovators\, and startup founders in oncology\, immunology\, and neuroscience\, this event will deliver practical knowledge to help maximize meaningful collaborations in 2026 and beyond. \nPlease note: This is an apply-to-attend event. The application deadline is March 11th\, and approved attendees will be notified by March 16. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/herding-cats-3-0-big-pharma-panel/
LOCATION:JLABS@SSF\, 329 OYSTER POINT BLVD.\, SOUTH SF\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260401T080000
DTEND;TZID=America/Los_Angeles:20260401T090000
DTSTAMP:20260604T012954
CREATED:20260327T183718Z
LAST-MODIFIED:20260327T183718Z
UID:10001046-1775030400-1775034000@www.califesciences.org
SUMMARY:Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
DESCRIPTION:Join BioIVT and France Tissue Bank experts to explore how high-quality biospecimens\, longitudinal data\, and regulatory rigor drive the future of biomarker discovery. Using an Alzheimer’s disease use case\, discover the critical role of pre-analytical rigor\, matched sample sets\, and demographic diversity. Learn to navigate ISO standards\, optimize sample selection for AI and clinical diagnostics\, and ensure reproducibility for your scientific projects. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/precision-in-human-biological-samples/
LOCATION:https://www.califesciences.org/event/precision-in-human-biological-samples/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260330T083000
DTEND;TZID=America/Los_Angeles:20260330T163000
DTSTAMP:20260604T012954
CREATED:20251113T181003Z
LAST-MODIFIED:20251113T181003Z
UID:10000946-1774859400-1774888200@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | San Diego
DESCRIPTION:Elevate the pace\, performance\, and culture of your company’s greatest assets. Built from over 30 years of success with more than 7\,500 graduates from over 1\,000 life science companies\, From the Laboratory to Leadership program guides first-time managers\, and those seeking to expand their management skills\, into capable business leaders. This fully redesigned program leverages extensive industry-specific knowledge and experience to utilize the most progressive and engaging professional development methods available. \nProgram dates: March 30\, April 13\, April 27\, and May 11 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-the-laboratory-to-leadership-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260330T083000
DTEND;TZID=America/Los_Angeles:20260330T140000
DTSTAMP:20260604T012954
CREATED:20260217T165533Z
LAST-MODIFIED:20260217T165533Z
UID:10001019-1774859400-1774879200@www.califesciences.org
SUMMARY:Development of Radiopharmaceuticals: Fundamentals\, Landscape\, BD Deals\, CMC Challenges\, Theranostic Development\, and IP strategies
DESCRIPTION:This workshop offers a comprehensive deep dive into the rapidly evolving field of radiopharmaceuticals. The agenda spans the full development lifecycle\, beginning with a high-level view of the market landscape\, deal-making trends\, and future directions in oncology and beyond. Expert sessions will tackle critical technical hurdles\, including CMC challenges\, theranostic development\, and manufacturing for first-in-human trials. Attendees will also gain insights into clinical strategies\, such as dose selection and PET imaging agents\, alongside essential legal considerations regarding IP strategy. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/development-of-radiopharmaceuticals/
LOCATION:https://www.califesciences.org/event/development-of-radiopharmaceuticals/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T110000
DTEND;TZID=America/Los_Angeles:20260326T120000
DTSTAMP:20260604T012954
CREATED:20260302T185341Z
LAST-MODIFIED:20260302T185341Z
UID:10001026-1774522800-1774526400@www.califesciences.org
SUMMARY:Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
DESCRIPTION:During the past seven months\, biopharma companies have had to contend with unprecedented change within the upper echelons of the FDA. Among other challenges\, executives at small and medium companies have reported communication issues\, misaligned expectations and media leaks while attempting to get their products across the regulatory finish line. \nNotably\, many of these investigational therapies have targeted rare diseases affecting primarily children—products that FDA Commissioner Marty Makary and Center for Biologics and Research Director Vinay Prasad have vowed to expedite to the market. \nAt the same time\, the FDA has outlined its commitment to aligning with drug sponsors on the regulatory approval process\, with Makary and Prasad stating in a JAMA article published in June that they intend to provide “the regulatory navigation that [small] companies may lack internally.” \nIt’s clear that both the FDA and biopharma companies developing medicines for rare diseases want the same thing but there remains a disconnect. This panel discussion will look at how to leverage FDA frameworks\, define expectations and adopt modern technologies\, including AI and in silico models\, to increase the likelihood of success. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/aligning-with-the-fda-on-a-regulatory-pathway/
LOCATION:https://www.califesciences.org/event/aligning-with-the-fda-on-a-regulatory-pathway/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260604T012954
CREATED:20251110T193126Z
LAST-MODIFIED:20260323T152242Z
UID:10000938-1774396800-1774483199@www.califesciences.org
SUMMARY:MedTech Day
DESCRIPTION:California Life Sciences\, together with our partner\, AdvaMed\, invite you to join us for MedTech Day – a premier event dedicated to educating state lawmakers about the vital role California’s medical technology sector plays in improving patient lives and strengthening our state’s healthcare ecosystem. \nAdvanced registration for the lobby day is not closed. Please contact Emily Morgan\, emorgan@califesciences.org\, to participate. Membership with CLS or AdvaMed is required to participate. \nFollowing a full day of meetings between MedTech leaders and legislators\, join us for the MedTech Innovation Reception — an opportunity for meaningful\, informal engagement among MedTech executives\, patient advocates\, and California policymakers. \nAll are welcome. Light food and beverages will be provided. \nRSVP for the reception »
URL:https://www.califesciences.org/event/medtech-day-2026/
LOCATION:CA
CATEGORIES:Advocacy & Government Relations,California Life Sciences,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/03.25-MedTech-Day.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T110000
DTEND;TZID=America/Los_Angeles:20260319T120000
DTSTAMP:20260604T012954
CREATED:20260302T213350Z
LAST-MODIFIED:20260302T214421Z
UID:10001029-1773918000-1773921600@www.califesciences.org
SUMMARY:Lab Solutions & Products | BIO Savings Week
DESCRIPTION:Designed for lab managers and R&D leaders\, this session explores the lab solutions and benefits that support research environments—from equipment and lab supply procurement to safety and compliance. \nFeatured Partners:\n\nAirgas Healthcare | Dalton Speelman\, National Account Manager\, Airgas Life Sciences\nAmerican Laboratory Trading | Carrie Kleinle\, Director\, Product Marketing & Partner Engagement\nClean Harbors | Lori Cotsack\, Corporate Account Manager\nSU Group | Ric Kunnert\, Regional Sales Manager\nUniFirst | Jim Tilton\, National Sales Manager\nVWR\, part of Avantor | Tina Nuthulaganti\, Director\, Strategic Alliances\n\n\n\n\nBIO Savings Week connects life science companies with the lab and business solutions available through their BIO or state life science association membership. Across three days\, you will hear directly from BIO Business Solutions’ preferred providers about programs tailored to different roles—from founders and operations leaders to lab managers and admins. \nAll sessions are open to BIO and state affiliate members and include Q&A and life science-focused strategies. \nBIO Business Solutions® is the largest cost-savings program for the life sciences industry\, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies\, insurance\, office essentials\, and more\, all at no additional cost to members. \nDay 1 – Foundational Tools (March 17\, 2:00–3:00 p.m.\, Eastern Time)\nDay 2 – Core Business Operations Support (March 18\, 2:00–3:00 p.m.\, Eastern Time)\nDay 3 – Lab Solutions & Products (March 19\, 2:00–3:00 p.m.\, Eastern Time) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bio-savings-week-2026-lab-webinar/
LOCATION:CA
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T090000
DTEND;TZID=America/Los_Angeles:20260319T100000
DTSTAMP:20260604T012954
CREATED:20260312T164004Z
LAST-MODIFIED:20260312T164004Z
UID:10001038-1773910800-1773914400@www.califesciences.org
SUMMARY:Empowering Success in Small Pharma / Biotech: Leveraging People and Process for Optimal Results
DESCRIPTION:Scaling a small or mid‑sized biotech isn’t about having endless resources—it’s about using the ones you do have with precision. In these organizations\, people are the engine of innovation. They push research forward\, uphold quality\, and keep the company aligned with regulatory expectations. Even when work is outsourced\, strong internal oversight and clear direction remain essential. \nBut people alone aren’t enough. Sustainable growth comes from pairing great talent with great processes. When teams have well‑designed workflows early on\, they move faster\, collaborate more effectively\, and avoid costly pitfalls that emerge later in development. \nThat’s exactly what we’ll dig into in our upcoming webinar. In this session\, subject‑matter experts from Halloran will share practical insights and real‑world experience on how to bring people and processes together to drive scalable growth. \nWe’ll Cover:\n\nHow small pharma/biotech leaders can strategically align people and processes\nProcess‑driven methods that boost efficiency\, quality\, and compliance\nPractical ways to strengthen collaboration and continuous improvement\nReal examples of organizations that have successfully optimized both\n\nIf you’re leading a growing biotech and want to scale without losing agility\, this conversation will be worth your time. Reserve your spot and join us. \nSpeakers:\nMeghan Patterson (She/Her/Hers) – VP\, Executive Partner\nLyn Agostinelli – Principal Consultant\, Clinical Operations \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/empowering-success-in-small-pharma/
LOCATION:https://www.califesciences.org/event/empowering-success-in-small-pharma/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260318T120000
DTEND;TZID=America/New_York:20260318T130000
DTSTAMP:20260604T012954
CREATED:20260225T171753Z
LAST-MODIFIED:20260225T171753Z
UID:10001021-1773835200-1773838800@www.califesciences.org
SUMMARY:Safer Labs Through Filtration: Mitigating Overlooked Sources of Chemical Inhalation Exposure
DESCRIPTION:Laboratories often prioritize chemical fume hoods to mitigate chemical inhalation hazards\, yet many subtle sources of exposure remain overlooked. Benchtop chemistry\, common lab equipment (such as balances\, 3D printers\, HPLC\, ICP-MS)\, and chemical storage can all contribute to airborne contaminants. Over time\, Permissible Exposure Limits (PEL) and Threshold Limit Values (TLV) continue to decrease\, underscoring the importance of minimizing any level of chemical inhalation risk. This webinar explores how Erlab’s ecosystem of filtration solutions offer practical\, energy-efficient strategies to reduce exposure and enhance laboratory safety. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/safer-labs-through-filtration/
LOCATION:https://www.califesciences.org/event/safer-labs-through-filtration/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260318T110000
DTEND;TZID=America/Los_Angeles:20260318T120000
DTSTAMP:20260604T012954
CREATED:20260302T213150Z
LAST-MODIFIED:20260302T213151Z
UID:10001028-1773831600-1773835200@www.califesciences.org
SUMMARY:Core Business Operations Support | BIO Savings Week
DESCRIPTION:BIO Savings Week connects life science companies with the lab and business solutions available through their BIO or state life science association membership. Across three days\, you will hear directly from BIO Business Solutions’ preferred providers about programs tailored to different roles—from founders and operations leaders to lab managers and admins. \nAll sessions are open to BIO and state affiliate members and include Q&A and life science-focused strategies. \nBIO Business Solutions® is the largest cost-savings program for the life sciences industry\, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies\, insurance\, office essentials\, and more\, all at no additional cost to members. \nDay 1 – Foundational Tools (March 17\, 2:00–3:00 p.m.\, Eastern Time)\nDay 2 – Core Business Operations Support (March 18\, 2:00–3:00 p.m.\, Eastern Time)\nDay 3 – Lab Solutions & Products (March 19\, 2:00–3:00 p.m.\, Eastern Time) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bio-savings-week-2026-2/
LOCATION:https://www.califesciences.org/event/bio-savings-week-2026-2/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260317T130000
DTEND;TZID=America/New_York:20260317T140000
DTSTAMP:20260604T012954
CREATED:20260213T185123Z
LAST-MODIFIED:20260213T185123Z
UID:10001014-1773752400-1773756000@www.califesciences.org
SUMMARY:Live Webinar - Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium
DESCRIPTION:Artificial intelligence is rapidly reshaping the life sciences\, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs\, biologics\, and devices. As adoption grows across regulators\, pharmaceutical companies\, technology developers\, nonprofits\, and collaborative consortia\, the need for clear\, risk-based frameworks for validation\, governance and human oversight becomes increasingly critical. \nThis webinar introduces the DIA Artificial Intelligence Consortium\, a neutral\, public‑private partnership that convenes regulators\, biopharmaceutical companies\, academia\, and technology providers\, including FDA\, Health Canada\, MHRA\, PMDA\, IQVIA\, Gilead\, Otsuka\, BeOne Medicines\, Beth Israel Deaconess Medical Center–Yale School of Medicine\, and others. Consortium partners are building a 7‑step AI use case classification framework\, risk‑proportionate validation and monitoring approaches\, and aligned regulatory terminology that reflect how global authorities are stratifying AI use\, from low‑risk administrative automation to decision‑critical analyses influencing clinical or labeling decisions. \nSpeakers will walk through use cases across regulatory\, clinical\, and manufacturing contexts and highlight where human‑in‑the‑loop oversight\, documentation expectations\, and Good Machine Learning Practice–aligned validation should differ by context of use. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/operationalizing-ai-in-drug-development/
LOCATION:https://www.califesciences.org/event/operationalizing-ai-in-drug-development/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T110000
DTEND;TZID=America/Los_Angeles:20260317T120000
DTSTAMP:20260604T012954
CREATED:20260302T213335Z
LAST-MODIFIED:20260302T214455Z
UID:10001027-1773745200-1773748800@www.califesciences.org
SUMMARY:Foundational Tools | BIO Savings Week
DESCRIPTION:A focused look at the foundational tools early-stage life science companies need to launch and scale. Learn how membership benefits support HR\, finance\, compliance\, and leadership decisions during the earliest stages. \nFeatured Partners:\n\nADP HR | Greg Hassan\, Director of Franchise & Affiliations\nADP Tax Credits | Jose Arellano\, Senior Director of Channel Strategy\nBrex | Gaby Levey\, Startup Partnerships Manager\nBiotechExec | Steve Joseph\, Executive Vice President\, Strategic Partnerships\nPSC Biotech | Brandon Clough\, Managing Director of Operations – Central Region\nPSC Software | Clark Chandler\, Manager\, Sales Development\n\n\n\nBIO Savings Week connects life science companies with the lab and business solutions available through their BIO or state life science association membership. Across three days\, you will hear directly from BIO Business Solutions’ preferred providers about programs tailored to different roles—from founders and operations leaders to lab managers and admins. \nAll sessions are open to BIO and state affiliate members and include Q&A and life science-focused strategies. \nBIO Business Solutions® is the largest cost-savings program for the life sciences industry\, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies\, insurance\, office essentials\, and more\, all at no additional cost to members. \nDay 1 – Foundational Tools (March 17\, 2:00–3:00 p.m.\, Eastern Time)\nDay 2 – Core Business Operations Support (March 18\, 2:00–3:00 p.m.\, Eastern Time)\nDay 3 – Lab Solutions & Products (March 19\, 2:00–3:00 p.m.\, Eastern Time) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bio-savings-week-2026-foundational-tools/
LOCATION:CA
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T084500
DTEND;TZID=America/Los_Angeles:20260317T173000
DTSTAMP:20260604T012954
CREATED:20260202T165726Z
LAST-MODIFIED:20260202T165726Z
UID:10000977-1773737100-1773768600@www.califesciences.org
SUMMARY:Oncology Preclinical Models and Pharmacology Studies for Translational Research: Fundamentals\, Applications and Case Studies
DESCRIPTION:Developing effective cancer therapies remains a major challenge\, with low translational success despite advances in molecular oncology. A key barrier is the limited predictive power of traditional preclinical models and the need for robust pharmacological evaluation. \nThis workshop addresses these challenges by exploring preclinical models and pharmacology strategies essential for oncology drug development. With the rise of complex modalities including immunotherapies\, ADCs\, and cell-based treatments\, refining preclinical evaluation is critical to improve clinical translation. \nKey Topics\n\nPreclinical Development – Target validation\, mechanism of action\, efficacy profiling.\nIn Vivo Models – Xenografts\, GEMMs: strengths and limitations.\nPharmacokinetics – ADME\, PK/PD modeling for oncology agents.\nPDX Models – Preserving tumor heterogeneity for predictive insights.\n3D Cultures – Spheroids and organoids for physiologic relevance.\nOrgan-on-Chip – Microfluidic systems for dynamic tumor modeling.\nAI/ML Applications – Predictive modeling\, biomarker discovery\, patient stratification.\n\nREGISTER»
URL:https://www.califesciences.org/event/oncology-preclinical-models-and-pharmacology-studies-for-translational-research-fundamentals/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T080000
DTEND;TZID=America/Los_Angeles:20260317T150000
DTSTAMP:20260604T012954
CREATED:20251008T161203Z
LAST-MODIFIED:20251113T182317Z
UID:10000910-1773734400-1773759600@www.califesciences.org
SUMMARY:QC Micro Summit
DESCRIPTION:Get ready for three days of presentations covering the most important topics affecting pharmaceutical quality control and microbiology. There will be opportunities to ask questions and network with industry leaders and like-minded peers. This is an event unlike any other. It is designed to put you in control of your organization’s quality by delivering the key insights and actionable information to excel your lab’s efficiency and operations. You’ll be not just a participant but a contributor shaping the future of quality control. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/charles-river-qc-micro-summit-2026/
LOCATION:Cape Rey Hilton Resort & Spa\, 1 Ponto Road\, Carlsbad\, CA\, 92011\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260320
DTSTAMP:20260604T012954
CREATED:20260312T160326Z
LAST-MODIFIED:20260312T160326Z
UID:10001035-1773705600-1773964799@www.califesciences.org
SUMMARY:BSMA 18th Annual Summit 2026
DESCRIPTION:The Bio Supply Management Alliance (BSMA) invites global leaders\, innovators\, and changemakers in biopharma supply chain management to join the 18th Annual BSMA Conference — the industry’s premier gathering for advancing the future of life sciences supply chains. \nWith more than 200 companies represented and over 350 subject matter experts\, executives\, service providers\, and technology leaders\, this is your opportunity to shape and advance the way therapies are delivered to patients worldwide. \n\nCLS members receive a 25% discount to attend the full conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bsma-18th-annual-summit-2026/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260312T163000
DTEND;TZID=America/Los_Angeles:20260312T193000
DTSTAMP:20260604T012954
CREATED:20260303T205021Z
LAST-MODIFIED:20260304T211703Z
UID:10001032-1773333000-1773343800@www.califesciences.org
SUMMARY:Future of Biotech x AI: AI in Peptide Drug Discovery
DESCRIPTION:An exclusive in-person expert panel co-hosted by Tech Brews\, TechBio Transformers\, and Magnet Ventures. Sponsored by DLA Piper. \n​Featuring Special Guests:\n​Professor Katrin J Svensson is an Associate Professor of Pathology at Stanford University. She leads a lab focused on discovering previously unidentified peptide hormones that regulate metabolism\, appetite\, and energy balance. Her work integrates computational prediction\, human genetics\, and in-vivo models to uncover new molecular targets for obesity and diabetes. With a strong IP portfolio and active translational pipeline\, she bridges academic discovery with biotech and pharma partnerships. \n​Jonathan MacQuitty is a Partner at Lightspeed Venture Partners. He brings over three decades of experience across biotech entrepreneurship and venture capital. Jonathan has served as founding CEO of multiple venture-backed life science companies\, including GenPharm International and Forty Seven Inc.\, before transitioning into investing. At Lightspeed\, he partners closely with founders building transformative healthcare companies\, bringing both operator experience and investor perspective to early-stage innovation. \n​Cyrus Harmon is the Co-Founder & CEO at Vilya Therapeutics. Cyrus is a biotech entrepreneur focused on oncology drug development and next-generation discovery platforms. His work spans modern research tools\, computational biology\, and chemistry applied to advancing human health. At Vilya Therapeutics\, he leads efforts to translate scientific innovation into clinically impactful therapeutics. \n​​Danjuma Quarless is Senior Director of AI Innovation at Lilly Ventures\, where he focuses on early-stage investing at the intersection of AI and drug development. His career spans computational biology\, corporate business development\, and strategic biopharma venture investing. He began as a senior scientist leading statistical analytics for major population genomics initiatives including the UK Biobank and Genomics Finland\, before transitioning into therapeutics investing with a focus on early-stage biotech and ecosystem engagement. Danjuma holds a PhD in Biomedical Sciences from UC San Diego and an MBA from the Kellogg School of Management at Northwestern University. \n​Moderator : Darren Platt\, Partner at Magnet Ventures \n​​​​​​​Who should Attend:\nWhether you’re experienced or exploring the healthcare or life science ecosystem\, this series provides valuable insights and practical tools by experts to help you excel in your career or as an entrepreneur. \n​​​​​​​​About the Event Series:\nWelcome to the Bay Area edition of the “Future of Biotech x AI” event series! Held quarterly\, this event series features an expert panel discussing their hot takes and insights on the future of Biotech and AI. Most suited for biotech professionals\, entrepreneurs\, and investors to learn\, gain insights and network. \n​​​​​​​Organizers:\nTech Brews is an open and inclusive global community for founders and innovators in healthtech\, biotech and life sciences. Founded by Dr Terence Tan\, we have more than 2000 members globally\, Tech Brews hosts regular events including founder fireside chats\, investor panels\, and startup pitch nights. Tech Brews has chapters in San Francisco\, Los Angeles\, Singapore\, Hong Kong\, Japan\, Shenzhen\, India\, South Africa\, London\, and Dubai. \n​​TechBio Transformers is a community of scientists\, product managers\, computational biologists\, academics\, and engineers who work on the world’s most important problems at the intersection of biology\, software\, and AI. \n​​Magnet Ventures focuses on AI-driven biotech investments\, specifically on computational approaches to biological drug discovery and therapeutic delivery. \n​Sponsor:\nDLA Piper is a law firm with offices in over 40 countries across the Americas\, Asia Pacific\, Europe\, Africa\, and the Middle East. With a portfolio of services to match every stage of the business lifecycle\, we combine practice area knowledge with modern industry insights and an expansive geographic footprint so our global solutions are tailored\, seamless and ready to meet your toughest challenges. \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/future-of-biotech-x-ai/
LOCATION:Palo Alto\, Palo Alto\, CA\, 94402\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260310T120000
DTEND;TZID=America/New_York:20260310T130000
DTSTAMP:20260604T012954
CREATED:20260302T172834Z
LAST-MODIFIED:20260302T172834Z
UID:10001025-1773144000-1773147600@www.califesciences.org
SUMMARY:ERP Readiness | What Should You Consider Before You Start an Implementation?
DESCRIPTION:ERP systems can transform your business—if you’re ready. This webinar highlights the critical steps organizations must take before kicking off an ERP project. We’ll walk through segment and dimension design\, continuous close readiness\, accounting and operational alignment\, the importance of governance and change management\, and considering the alignment with your internal AI strategy. Perfect for finance\, operations\, and leadership teams considering technology transformation. \nLearning Objectives\n\nIdentify the critical steps organizations must take before kicking off an ERP project.\nRecognize how to align accounting and operational processes to support effective ERP design\, reporting\, and execution.\nDiscover the role of governance and change management in ERP implementations and assess how ERP planning should align with an organization’s internal AI strategy.\n\nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/erp-readiness-webinar/
LOCATION:https://www.califesciences.org/event/erp-readiness-webinar/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260309T090000
DTEND;TZID=America/Los_Angeles:20260309T100000
DTSTAMP:20260604T012954
CREATED:20260213T183602Z
LAST-MODIFIED:20260213T183602Z
UID:10001011-1773046800-1773050400@www.califesciences.org
SUMMARY:North American UGM 2026
DESCRIPTION:Connect With Your Peers in Biotherapeutic Characterization\nWe’re hosting our North American User Group Meeting in Cambridge MA\, featuring a panel discussion with leaders in biopharma characterization. \nThe focus: Is your data ready for AI and automation? We’ll be exploring what it takes to build rich\, clean\, and well-structured data foundations for effective AI-driven workflows. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/north-american-ugm-2026/
LOCATION:300 Technology Square\, 300 Technology Square\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260312
DTSTAMP:20260604T012954
CREATED:20260105T190942Z
LAST-MODIFIED:20260122T165049Z
UID:10000971-1773014400-1773273599@www.califesciences.org
SUMMARY:Informa Connect BioProcess International West
DESCRIPTION:BPI US West 2026: The Premier Bioprocessing Conference Returns to San Diego\nJoin 800+ biopharma professionals at BPI US West 2026\, taking place March 9-11 in San Diego\, California. This flagship west coast bioprocessing event brings together global leaders to explore advancements from cell line development to commercial manufacturing\, creating a gateway to integrated systems\, technical breakthroughs\, and expert networking. \nWhat to Expect: \n\nCutting-edge developments in monoclonal antibodies\, vaccines\, cell & gene therapies\, and advanced biologics manufacturing\nInsights from top CMOs\, CROs\, and technology innovators\n90+ exhibitors showcasing breakthrough solutions and live product demonstrations\nScientific poster sessions highlighting groundbreaking research\nExclusive networking opportunities with industry pioneers\n\nDiscover strategies that accelerate product development and market entry while connecting with the bioprocessing community’s most influential scientists and business leaders. From upstream and downstream processing to quality control and regulatory compliance\, BPI US West covers every aspect of modern biomanufacturing. \nDon’t miss this essential gathering of bioprocessing innovators shaping the future of life sciences manufacturing. \n\nCLS members receive a 50% discount to attend the full conference and access to 125+ scientific presentations across 5 tracks designed to optimize efficiency and innovation across bioprocessing. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/informa-connect-bioprocess-international-west/
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260304T100000
DTEND;TZID=America/Los_Angeles:20260304T113000
DTSTAMP:20260604T012954
CREATED:20260226T231138Z
LAST-MODIFIED:20260226T231138Z
UID:10001024-1772618400-1772623800@www.califesciences.org
SUMMARY:ACROBiosystems GMP Factory Virtual Open Day
DESCRIPTION:Welcome to ACROBiosystems’ Intelligent GMP Facility Online Open Day for an immersive virtual tour of our facility designed to help tackle your biologics supply chain & compliance challenges. \nAgenda (Around 1-1.5 Hours)\n\n15 Mins: ACROBiosystems GMP Facilities & QMS Introduction\n30 Mins: Immersive Virtual Facility Tour\n30 Mins: Live Q&A with Process & Quality Experts\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/acrobiosystems-gmp-factory-virtual-open-day/
LOCATION:https://www.califesciences.org/event/acrobiosystems-gmp-factory-virtual-open-day/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260304T060000
DTEND;TZID=America/Los_Angeles:20260304T070000
DTSTAMP:20260604T012954
CREATED:20260112T180026Z
LAST-MODIFIED:20260112T180026Z
UID:10000973-1772604000-1772607600@www.califesciences.org
SUMMARY:Decoding IgG2 Disulfide Isoforms with Native CEX-MS and Advanced Peptide Mapping
DESCRIPTION:About this Webinar\nJoin Yann Leblanc from Servier R&D as he shares insights into characterizing IgG2 disulfide isoforms using native cation exchange chromatography-mass spectrometry (CEX-MS) combined with advanced peptide mapping. The IgG2 subclass presents unique structural complexity—like a molecular blueprint with multiple architectural variants—where disulfide-bonded isoforms (A\, A/B\, and B) form different structural scaffolds that may influence biological function and therapeutic activity. \nThis presentation demonstrates the analytical framework for mapping these structural variations. Using native LC-MS workflows integrated with Protein Metrics’ Byos and Byonic software\, the approach enables high-resolution separation and characterization of IgG2 disulfide isoforms while preserving their native structure. Discover how this method resolves\, identifies\, and quantifies these critical structural variants directly under near-physiological conditions\, providing the foundation for therapeutic antibody development. \nKey Takeaways:\n\nNative CEX-MS Workflow: See how volatile salts and pH-gradient Cation Exchange Chromatography preserve native antibody structure while separating F(ab′)₂ fragments for high-quality mass spectra.\nAutomated Data Analysis: Learn how Byos and Byonic software streamline intact mass deconvolution and disulfide bond assignment using the Isotope Envelope Confidence (IEC) scoring system.\nComplete Structural Mapping: Discover how middle-up strategies with peptide mapping provide detailed profiling of disulfide bonds\, revealing molecular heterogeneity important for quality control and biosimilar comparability.\n\nWhy This Matters\nDisulfide bond heterogeneity in IgG2 is a critical quality attribute influencing antibody biological functions. Having the right analytical blueprint enables biopharmaceutical scientists to monitor and control product quality during manufacturing\, understand the structural framework of isoform formation and rearrangement\, support biosimilar comparability studies\, and build more effective therapeutic antibody development pipelines. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/decoding-igg2-disulfide-isoforms/
LOCATION:https://www.califesciences.org/event/decoding-igg2-disulfide-isoforms/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260604T012954
CREATED:20260107T203135Z
LAST-MODIFIED:20260107T204201Z
UID:10000972-1772582400-1772755199@www.califesciences.org
SUMMARY:Festival of Biologics
DESCRIPTION:The Festival of Biologics is America’s most exciting biologics event. \nTerrapin brings together pharma and biotech\, academics and research institutes\, along with their partners across the value chain. Across antibodies\, immunotherapy and biosimilars\, participants share research\, create new partnerships\, and tackle challenges from clinical trials to commercialization. \nCLS members receive 20% off registration. Contact your account manager or bd@califesciences.org for more details. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/terrapin-festival-of-biologics-2026/
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260301T090000
DTEND;TZID=America/Los_Angeles:20260301T100000
DTSTAMP:20260604T012954
CREATED:20260213T183036Z
LAST-MODIFIED:20260213T183036Z
UID:10001010-1772355600-1772359200@www.califesciences.org
SUMMARY:Automating Peptide Mapping: From Bench to Batch in Half the Time
DESCRIPTION:Peptide mapping is indispensable for biotherapeutic characterization\, but manual sample preparation and data analysis can consume days of analyst time each week. In this webinar\, researchers from Genentech’s Protein Analytical Chemistry group share how they automated three core peptide mapping workflows — disulfide mapping\, reduced Lys-C PTM characterization\, and Asp-N glycation analysis — using the TECAN Fluent 1080 liquid handling platform and Byos software from Protein Metrics. The result: a validated 30% improvement in throughput\, freeing 2-3 days per week while maintaining analytical quality comparable to manual methods. \nKey Takeaways\n\nAutomation without compromise — See head-to-head chromatographic and quantitative comparisons between manual and automated preparations across all three workflows\, with RSD <15% for PTM quantification\nOne-click data analysis — Learn how preset Byos workflows transform complex disulfide\, deamidation\, and glycation analysis into a streamlined drag-and-drop process with compliance-ready reporting\nReal-world time savings — Understand exactly where the 2-3 days per week are recovered: 7-9 hours from sample prep automation plus 1-2 days from standardized data analysis and reporting\nTranslatable methods — Walk away with a practical framework for automating your own peptide mapping workflows\, including design considerations for buffer exchange steps and multi-enzyme digestion protocols\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/automating-peptide-mapping-from-bench-to-batch/
LOCATION:https://www.califesciences.org/event/automating-peptide-mapping-from-bench-to-batch/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
END:VCALENDAR